Abstract
Cancer is the leading cause of human death worldwide. In spite of medical advancements, cancer cases are rising globally where Colorectal Cancer (CRC) frequency is third in position in males and second in females. Colorectal cancer (CRC) is a disease where abnormal growth of cells occurs in the colon and rectal area of the alimentary canal. Factors like food habits, smoking, alcohol consumption, obesity, gut dysbiosis, etc. increase CRC risk. The CRC patients suffer not only from painful surgical treatments but also bear the side effects of palliative radiotherapy, chemotherapy, and therapeutic drugs used for the same. Dietary probiotics have great potential in the prevention and management of CRC due to their anticancer properties. The present review discusses the various risk factors of colorectal cancer and important role of probiotic supplements to prevent it. It highlights some of the proposed mechanisms of probiotics for their protective role against CRC. The prevention through modifiable risk factors and probiotic dietary supplements can save the patients from the trauma of the disease. Probiotics regulate gut dysbiosis and prevent CRC through different mechanisms, so more research work and clinical trials in humans with respect to it are expected in the future.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Ahmad, R.: Emerging trends in colorectal cancer: dysregulated signaling pathways (review). Int. J. Mol. Med. 47(3), 14 (2021). https://doi.org/10.3892/ijmm.2021.4847
Alomair, A.O., Masoodi, I., Alyamani, E.J., Allehibi, A.A., Qutub, A.N., Alsayari, K.N., Altammami, M.A., Alshanqeeti, A.S.: Colonic mucosal microbiota in colorectal cancer: a single-center metagenomic study in Saudi Arabia. Gastroenterol. Res. Pract. 2018, 1–9 (2018). https://doi.org/10.1155/2018/5284754
Altonsy, M.O., Andrews, S.C., Tuohy, K.M.: Differential induction of apoptosis in human colonic carcinoma cells (Caco-2) by Atopobium, and commensal, probiotic and enteropathogenic bacteria: mediation by the mitochondrial pathway. Int. J. Food Microbiol. 137, 190–203 (2010). https://doi.org/10.1016/j.ijfoodmicro.2009.11.015
Amara, A.A., Shibl, A.: Role of probiotics in health improvement, infection control and disease treatment and management. Saudi Pharm J. 23(2), 107–114 (2015). https://doi.org/10.1016/j.jsps.2013.07.001
Aykan, N.F.: Red meat and colorectal cancer. Oncol. Rev. 9(1), 288 (2015). https://doi.org/10.4081/oncol.2015.288
Bäumler, A., Sperandio, V.: Interactions between the microbiota and pathogenic bacteria in the gut. Nature 535, 85–93 (2016). https://doi.org/10.1038/nature18849
Boleij, A., Tjalsma, H.: Gut bacteria in health and disease: a survey on the interface between intestinal microbiology and colorectal cancer. Biol. Rev. 87, 701–730 (2012)
Borowicki, A., Michelmann, A., Stein, K., Scharlau, D., Scheu, K., Obst, U., Glei, M.: Fermented wheat aleurone enriched with probiotic strains LGG and Bb12 modulates markers of tumor progression in human colon cells. Nutr. Cancer. 63(1), 151–160 (2011). https://doi.org/10.1080/01635581.2010.516874
Boyle, P., Langman, J.S.: ABC of colorectal cancer: epidemiology. BMJ 321(7264), 805–808 (2000). https://doi.org/10.1136/bmj.321.7264.805
Brenner, H., Kloor, M., Pox, C.P.: Colorectal cancer. Lancet 383(9927), 1490–1502 (2014)
Bron, P.A., Kleerebezem, M., Brummer, R.J., Cani, P.D., Mercenier, A., MacDonald, T.T., Garcia-Ródenas, C.L., Wells, J.M.: Can probiotics modulate human disease by impacting intestinal barrier function. Br. J. Nutr. 117(1), 93–107 (2017). https://doi.org/10.1017/S0007114516004037
Carethers, J.M., Jung, B.H.: Genetics and genetic biomarkers in sporadic colorectal cancer. Gastroenterology 149(5), 1177–1190 (2015). https://doi.org/10.1053/j.gastro.2015.06.047
Casanova, M.R., Azevedo-Silva, J., Rodrigues, L.R., Preto, A.: Colorectal cancer cells increase the production of short chain fatty acids by Propionibacterium freudenreichii impacting on cancer cells survival. Front. Nutr. 24, 5–44 (2018). https://doi.org/10.3389/fnut.2018.00044
CaTorre, L.A., Bray, F., Siegel, R.L., Ferlay, J., Lortet-Tieulent, J., Jemal, A.: Global cancer statistics, 2012. CA: Cancer J. Clin. 65(2), 87–108 (2015). https://doi.org/10.3322/caac.21262
Chang, C.J., Lin, T.L., Tsai, Y.L., Wu, T.R., Lai, W.F., Lu, C.C., Lai, H.C.: Next-generation probiotics in disease amelioration. J. Food Drug Anal. 27(3), 615–622 (2019). https://doi.org/10.1016/j.jfda.2018.12.011
Chang, J.H., Shim, Y.Y., Cha, S.K., Reaney, M.J.T., Chee, K.M.: Effect of Lactobacillus acidophilus KFRI342 on the development of chemically induced precancerous growths in the rat colon. J. Med. Microbiol. 61, 361–368 (2012)
Chen, E., Li, Q., Wang, H., Yang, F., Min, L., Yang, J.: MiR-92a promotes tumorigenesis of colorectal cancer, a transcriptomic and functional-based study. Biomed. Pharmacother. 106, 1370–1377 (2018). https://doi.org/10.1016/j.biopha.2018.07.098
Dalal, N., Jalandra, R., Sharma, M., Prakash, H., Makharia, G.K., Solanki, P.R., Singh, R., Kumar, A.: Omics technologies for improved diagnosis and treatment of colorectal cancer: technical advancement and major perspectives. Biomed. Pharmacother. 131, 110648 (2020). https://doi.org/10.1016/j.biopha.2020.110648
DeGruttola, A.K., Low, D., Mizoguchi, A., Mizoguchi, E.: Current understanding of dysbiosis in disease in human and animal models. Inflamm. Bowel Dis. 22(5), 1137–1150 (2016). https://doi.org/10.1097/MIB.0000000000000750
Dinis Oliveira, R.J.: Oxidative and non-oxidative metabolomics of ethanol. Curr. Drug Metab. 17, 327–335 (2016). https://doi.org/10.2174/1389200217666160125113806
Duangjitcharoen, Y., Kantachote, D., Prasitpuripreecha, C., Peerajan, S., Chaiyasut, C.: Selection and characterization of probiotic lactic acid bacteria with heterocyclic amine binding and nitrosamine degradation properties. J. Appl. Pharm. Sci. 4(7), 14–23 (2014). https://doi.org/10.7324/JAPS.2014.40703
Elamin, E., Masclee, A., Troost, F., Dekker, J., Jonkers, D.: Activation of the epithelial-to-mesenchymal transition factor snail mediates acetaldehyde-induced intestinal epithelial barrier disruption. Alcohol Clin. Exp. Res. 38(2), 344–353 (2014). https://doi.org/10.1111/acer.12234
Engen, P.A., Green, S.J., Voigt, R.M., Forsyth, C.B., Keshavarzian, A.: The gastrointestinal microbiome: alcohol effects on the composition of intestinal microbiota. Alcohol Res. Curr. Rev. 37(2), 223–236 (2015)
Eslami, M., Yousefi, B., Kokhaei, P., Hemati, M., Nejad, Z.R., Arabkari, V., Namdar, A.: Importance of probiotics in the prevention and treatment of colorectal cancer. J. Cell. Physiol. 234(10), 17127–17143 (2019). https://doi.org/10.1002/jcp.28473
Fan, X., Jin, Y., Chen, G., Ma, X., Zhang, L.: Gut microbiota dysbiosis drives the development of colorectal cancer. Digestion 102(4), 508–515 (2021). https://doi.org/10.1159/000508328
Fijan, S.: Microorganisms with claimed probiotic properties: an overview of recent literature. Int. J. Environ. Res. Public Health 11(5), 4745–4767 (2014). https://doi.org/10.3390/ijerph110504745
Gagliardi, A., Totino, V., Cacciotti, F., Iebba, V., Neroni, B., Bonfiglio, G., Trancassini, M., Passariello, C., Pantanella, F., Schippa, S.: Rebuilding the gut microbiota ecosystem. Int. J. Environ. Res. Public Health 15(8), 1679 (2018). https://doi.org/10.3390/ijerph15081679
Galdeano, M.C., Cazorla, S.I., LemmeDumit, J.M., Vélez, E., Perdigón, G.: Beneficial effects of probiotic consumption on the immune system. Ann. Nutr. Metab. 74(2), 115–124 (2019). https://doi.org/10.1159/000496426
Gay, L.J., Mitrou, P.N., Keen, J., Bowman, R., Naguib, A., Cooke, J., Kuhnle, G.G., Burns, P.A., Luben, R., Lentjes, M., Khaw, K.T., Ball, R.Y., Ibrahim, A.E., Arends, M.J.: Dietary, lifestyle and clinicopathological factors associated with APC mutations and promoter methylation in colorectal cancers from the EPIC-Norfolk study. J. Path 228(3), 405–415 (2012). https://doi.org/10.1002/path.4085
Gerbaldo, G.A., Barberis, C., Pascual, L., Dalcero, A., Barberis, L.: Antifungal activity of two Lactobacillus strains with potential probiotic properties. FEMS Microbiol. Lett. 332(1), 27–33 (2012). https://doi.org/10.1111/j.1574-6968.2012.02570.x
Gilsing, A.M., Berndt, S.I., Ruder, E.H., Graubard, B.I., Ferrucci, L.M., Burdett, L., Weissfeld, J.L., Cross, A.J., Sinha, R.: Meat-related mutagen exposure, xenobiotic metabolizing gene polymorphisms and the risk of advanced colorectal adenoma and cancer. Carcinogenesis 33(7), 1332–1339 (2012). https://doi.org/10.1093/carcin/bgs158
Goldin, B.R., Gorbach, S.L.: Effect of Lactobacillus acidophilus dietary supplements on 1,2-dimethylhydrazine dihydrochloride-induced intestinal cancer in rats. J. Natl. Cancer Inst. 64(2), 263–265 (1980). https://doi.org/10.1093/jnci/64.2.263
Haas, S.L., Ye, W., Löhr, J.M.: Alcohol consumption and digestive tract cancer. Current opinion in clinical nutrition and metabolic care. Curr. Opin. Clin. Nutr. Metab. Care 15(5), 457–467 (2012). https://doi.org/10.1097/MCO.0b013e3283566699
Han, S., Lu, Y., Xie, J., Fei, Y., Zheng, G., Wang, Z., Liu, J., Lv, L., Ling, Z., Berglund, B., Yao, M., Li, L.: Probiotic gastrointestinal transit and colonization after oral administration: a long journey. Front. Cell. Infect. Microbiol. 11, 609722 (2021). https://doi.org/10.3389/fcimb.2021.609722
Hatakka, K., Holma, R., El-Nezami, H., Suomalainen, T., Kuisma, M., Saxelin, M., Poussa, T., Mykkänen, H., Korpela, R.: The influence of Lactobacillus rhamnosus LC705 together with Propionibacterium freudenreichii ssp. shermanii JS on potentially carcinogenic bacterial activity in human colon. Int. J. Food Microbiol. 128(2), 406–410 (2008). https://doi.org/10.1016/j.ijfoodmicro.2008.09.010
Heymann, H.M., Gardner, A.M., Gross, E.R.: Aldehyde-induced DNA and protein adducts as biomarker tools for alcohol use disorder. Trends Mol. Med. 242, 144–155 (2018)
Hills, R.D., Pontefract, B.A., Mishcon, H.R., Black, C.A., Sutton, S.C., Theberge, C.R.: Gut microbiome: profound implications for diet and disease. Nutrients 11(7), 1613 (2019). https://doi.org/10.3390/nu11071613
Ichikawa, Y., Ishikawa, T., Tanaka, K., Togo, S., Shimada, H.: Extracellular matrix degradation enzymes: Important factors in liver metastasis of colorectal cancer and good targets for anticancer metastatic therapy. Nihon Geka Gakkai Zasshi 102(5), 376–380 (2001)
Karczewski, J., Troost, F.J., Konings, I., Dekker, J., Kleerebezem, M., Brummer, R.J.M.: Regulation of human epithelial tight junction proteins by Lactobacillus plantarum in vivo and protective effects on the epithelial barrier. Am. J. Physiol. Gastrointest. Liver Physiol. 289, 851–859 (2010)
Kaźmierczak-Siedlecka, K., Hupp, T., Duchnowska, R., Marek-Trzonkowska, N., Połom, K.: Next-generation probiotics—Do they open new therapeutic strategies for cancer patients? Gut Microbes 14(1), e2035659 (2022)
Kaźmierczak-Siedlecka, K., Daca, A., Fic, M., van de Wetering, T., Folwarski, M., Makarewicz, W.: Therapeutic methods of gut microbiota modification in colorectal cancer management—fecal microbiota transplantation, prebiotics, probiotics, and synbiotics. Gut Microbes 11(6), 1518–1530 (2020a). https://doi.org/10.1080/19490976.2020.1764309
Kaźmierczak-Siedlecka, K., Folwarski, M., Ruszkowski, J., Skonieczna-Żydecka, K., Szafrański, W., Makarewicz, W.: Effects of 4 weeks of Lactobacillus plantarum 299v supplementation on nutritional status, enteral nutrition tolerance, and quality of life in cancer patients receiving home enteral nutrition - a double-blind, randomized, and placebo-controlled trial. Eur. Rev. Med. Pharmacol. Sci. 24(18), 9684–9694 (2020b). https://doi.org/10.26355/eurrev_202009_23059
Khosrovan, Z., Haghighat, S., Mahdavi, M.: The probiotic bacteria induce apoptosis in breast and colon cancer cells: an immunostimulatory effect. Immunoregulation 3(1), 37–50 (2000). https://doi.org/10.32598/Immunoregulation.3.1.5
Kim, S.E., Paik, H.Y., Yoon, H., Lee, J.E., Kim, N., Sung, M.K.: Sex- and gender-specific disparities in colorectal cancer risk. World J. Gastroenterol. 21(17), 5167–5175 (2015). https://doi.org/10.3748/wjg.v21.i17.5167
King, C.H., Desai, H., Sylvetsky, A.C., LoTempio, J., Ayanyan, S., Carrie, J., Crandall, K.A., Fochtman, B.C., Gasparyan, L., Gulzar, N.: Baseline human gut microbiota profile in healthy people and standard reporting template. PLoS ONE 14, e0206484 (2019)
Koveitypour, Z., Panahi, F., Vakilian, M., Peymani, M., SeyedForootan, F., Nasr Esfahani, M.H.: Signaling pathways involved in colorectal cancer progression. Cell Biosci. 9, 97 (2019). https://doi.org/10.1186/s13578-019-0361-4
Lazar, V., Ditu, L.M., Pircalabioru, G.G., Gheorghe, I., Curutiu, C., Holban, A.M., Picu, A., Petcu, L., Chifiriuc, M.C.: Aspects of gut microbiota and immune system interactions in infectious diseases, immunopathology, and cancer. Front. Immunol. 9, 1830 (2018). https://doi.org/10.3389/fimmu.2018.01830
Lee, N.K., Son, S.H., Jeon, E.B., Jung, G.H., Lee, J.Y., Paik, H.D.: The prophylactic effect of probiotic Bacillus polyfermenticus KU3 against cancer cells. J. Funct. Foods 14, 513–518 (2015)
Lilly, D.M., Stillwell, R.H.: Probiotics: growth-promoting factors produced by microorganisms. Sci 147(3659), 747–748 (1965). https://doi.org/10.1126/science.147.3659.747
Liu, Z., Qin, H., Yang, Z., Xia, Y., Liu, W., Yang, J., Jiang, Y., Zhang, H., Yang, Z., Wang, Y., Zheng, Q.: Randomised clinical trial: the effects of perioperative probiotic treatment on barrier function and post-operative infectious complications in colorectal cancer surgery—a double-blind study. Alimentary Pharmacol. Ther. 33(1), 50–63 (2011). https://doi.org/10.1111/j.1365-2036.2010.04492.x
Liu, J.R., Wang, S.Y., Chen, M.J., Yueh, P.Y., Lin, C.W.: The anti-allergenic properties of milk kefir and soymilk kefir and their beneficial effects on the intestinal microflora. J. Sci. Food Agric. 86, 2527–2533 (2006)
Lu, K., Dong, S., Wu, X., Jin, R., Chen, H.: Probiotics in cancer. Front Oncol 11, 638148 (2021). https://doi.org/10.3389/fonc.2021.638148
Ma, Y., Yang, Y., Wang, F., Zhang, P., Shi, C., Zou, Y., Qin, H.: Obesity and risk of colorectal cancer: a systematic review of prospective studies. PLoS ONE 8(1), e53916 (2013). https://doi.org/10.1371/journal.pone.0053916
Martín, R., Langella, P.: Emerging health concepts in the probiotics field: streamlining the definitions. Front. Microbiol. 10, 1047 (2019). https://doi.org/10.3389/fmicb.2019.01047
Madsen, K.L.: Enhancement of epithelial barrier function by probiotics. J. Epithel. Biol. Pharmacol. 5, 55–59 (2012)
Masrul, M., Nindrea, R.D.: Dietary fibre protective against colorectal cancer patients in Asia: a meta-analysis. Open Access Macedonian J. Med. Sci 7(10), 1723–1727 (2019). https://doi.org/10.3889/oamjms.2019.265
Mishra, S., Acharya, S.A.: Brief overview on probiotics: the health friendly microbes. Biomed. Pharmacol. J. 14(4), 1869–1880 (2021)
Morelli, L., Capurso, L.: FAO/WHO guidelines on probiotics: 10 years later. J. Clin. Gastroenterol. 46, S1–S2 (2012)
Nagao, M., Sugimura, T.: Carcinogenic factors in food with relevance to colon cancer development. Mut. Res. 290(1), 43–51 (1993). https://doi.org/10.1016/0027-5107(93)90031-a
National Institutes of Health What You Need to Know About Cancer of the Colon and Rectum. U.S. Department of Health and Human Services & National Institutes of Health, Bethesda, MD (2006)
Natividad, J.M., Verdu, E.F.: Modulation of intestinal barrier by intestinal microbiota: pathological and therapeutic implications. Pharmacol. Res. 69(1), 42–51 (2013). https://doi.org/10.1016/j.phrs.2012.10.007
Nieman, K.M., Romero, I.L., Van Houten, B., Lengyel, E.: Adipose tissue and adipocytes support tumorigenesis and metastasis. Biochim. Biophys. Cta 1831(10), 1533–1541 (2013). https://doi.org/10.1016/j.bbalip.2013.02.010
Ning, Y., Manegold, P.C., Hong, Y.K., Zhang, W., Pohl, A., Lurje, G., Winder, T., Yang, D., La Bonte, M.J., Wilson, P.M., Ladner, R.D., Lenz, H.J.: Interleukin-8 is associated with proliferation, migration, angiogenesis and chemosensitivity in vitro and in vivo in colon cancer cell line models. Int. J. Cancer Res 128(9), 2038–2049 (2018). https://doi.org/10.1002/ijc.25562
Ogino, S., Chan, A.T., Fuchs, C.S., Giovannucci, E.: Molecular pathological epidemiology of colorectal neoplasia: an emerging transdisciplinary and interdisciplinary field. Gut 60(3), 397–411 (2011). https://doi.org/10.1136/gut.2010.217182
Ogino, S., Kawasaki, T., Ogawa, A., Kirkner, G.J., Loda, M., Fuchs, C.S.: Fatty acid synthase overexpression in colorectal cancer is associated with microsatellite instability, independent of CpG island methylator phenotype. Human Path 38(6), 842–849 (2007). https://doi.org/10.1016/j.humpath.2006.11.018
Ohara, T., Yoshino, K., Kitajima, M.: Possibility of preventing colorectal carcinogenesis with probiotics. Hepato Gastroenterol. 57, 1411–1415 (2010)
Ohland, C.L., MacNaughton, W.K.: Probiotic bacteria and intestinal epithelial barrier function. Am. J. Physiol. Gastrointest. Liver Physiol. 298, 807–819 (2010)
Ohigashi, S., Sudo, K., Kobayashi, D., Takahashi, O., Takahashi, T., Asahara, T.: Changes of the intestinal microbiota, short chain fatty acids, and fecal pH in patients with colorectal cancer. Dig. Dis. Sci. 58, 1717–1726 (2013)
Petros, W.P., Younis, I.R., Ford, J.N., Weed, S.A.: Effects of tobacco smoking and nicotine on cancer treatment. Pharmacoth 32(10), 920–931 (2012). https://doi.org/10.1002/j.1875-9114.2012.01117
Pickard, J.M., Zeng, M.Y., Caruso, R., Núñez, G.: Gut microbiota: role in pathogen colonization, immune responses, and inflammatory disease. Immunol. Rev. 279(1), 70–89 (2017). https://doi.org/10.1111/imr.12567
Plaza-Diaz, J., Ruiz-Ojeda, F.J., Gil-Campos, M., Gil, A.: Mechanisms of action of probiotics. Adv. Nutr. 10, S49–S66 (2019). https://doi.org/10.1093/advances/nmy063
Pöschl, G., Seitz, H.K.: Alcohol and cancer. Alcohol Alcohol 39(3), 155–165 (2004)
Renehan, A.G., Roberts, D.L., Dive, C.: Obesity and cancer: pathophysiological and biological mechanisms. Arch. Physiol. Biochem. 114(1), 71–83 (2008). https://doi.org/10.1080/13813450801954303
Ries LAG, Melbert D, Krapcho M (1975–2005) SEER cancer statistics review. Bethesda, MD
Riondino, S., Roselli, M., Palmirotta, R., Della-Morte, D., Ferroni, P., Guadagni, F.: Obesity and colorectal cancer: role of adipokines in tumor initiation and progression. World J. Gastroenterol. 20(18), 5177–5190 (2014). https://doi.org/10.3748/wjg.v20.i18.5177
Sadeghi-Aliabadi, H., Mohammadi, F., Fazeli, H., Mirlohi, M.: Effects of Lactobacillus plantarum A7 with probiotic potential on colon cancer and normal cells proliferation in comparison with a commercial strain. Iran J. Basic Med. Sci. 10, 815–819 (2014)
Sánchez-Alcoholado, L., Ramos-Molina, B., Otero, A., Laborda-Illanes, A., Ordóñez, R., Medina, J.A., Gómez-Millán, J., Queipo-Ortuño, M.I.: The role of the gut microbiome in colorectal cancer development and therapy response. Cancers 12(6), 1406 (2020a). https://doi.org/10.3390/cancers12061406
Saarela, M.H.: Safety aspects of next generation probiotics. Curr. Opin. Food Sci. 30, 8–13 (2019). https://doi.org/10.1016/j.cofs.2018.09.001
Sankarapandian, V., VenmathiMaran, B.A., Rajendran, R.L., Jogalekar, M.P., Gurunagarajan, S., Krishnamoorthy, R., Gangadaran, P., Ahn, B.C.: An update on the effectiveness of probiotics in the prevention and treatment of cancer. Life 12(1), 59 (2022). https://doi.org/10.3390/life12010059
Santarelli, R.L., Pierre, F., Corpet, D.E.: Processed meat and colorectal cancer: a review of epidemiologic and experimental evidence. Nutr. Cancer 60(2), 131–144 (2008). https://doi.org/10.1080/01635580701684872
Satokari, R.: Modulation of gut microbiota for health by current and next-generation probiotics. Nutrients 11(8), 1921 (2019). https://doi.org/10.3390/nu11081921
Serban, D.E.: Gastrointestinal cancers: influence of gut microbiota, probiotics and prebiotics. Cancer Lett. 345(2), 258–270 (2014). https://doi.org/10.1016/j.canlet.2013.08.013
Shang, F., Jiang, X., Wang, H., Chen, S., Wang, X., Liu, Y., Guo, S., Li, D., Yu, W., Zhao, Z., Wang, G.: The inhibitory effects of probiotics on colon cancer cells: in vitro and in vivo studies. J. Gastrointest. Oncol. 11(6), 1224–1232 (2020). https://doi.org/10.21037/jgo-20-573
Singhal, N., Maurya, A.K., Mohanty, S., Kumar, M., Virdi, J.S.: Evaluation of bile salt hydrolases, cholesterol-lowering capabilities, and probiotic potential of enterococcus faecium isolated from rhizosphere. Front. Microbiol. 10, 1567 (2019). https://doi.org/10.3389/fmicb.2019.01567
Skibber J, Minsky B (2001) In: Hoff P, DeVita VT Jr, Hellmann S, Rosenberg SA (eds) Cancer: Principles & Practice of Oncology (6th ed), pp. 1216–1271. Lippincott Williams & Wilkins, Cancer of the Colon and Rectum, Philadelphia
Slattery, M.L., Curtin, K., Anderson, K., Ma, K.N., Ballard, L., Edwards, S., Schaffer, D., Potter, J., Leppert, M., Samowitz, W.S.: Associations between cigarette smoking, lifestyle factors, and microsatellite instability in colon tumors. J. Natl. Cancer Inst. 92(22), 1831–1836 (2000). https://doi.org/10.1093/jnci/92.22.1831
Śliżewska, K., Markowiak-Kopeć, P., Śliżewska, W.: The role of probiotics in cancer prevention. Cancers 13(1), 20 (2020). https://doi.org/10.3390/cancers13010020
Sobhani, I., Tap, J., Roudot-Thoraval, F., Roperch, J.P., Letulle, S., Langella, P., Corthier, G., Tran Van Nhieu, J., Furet, J.P.: Microbial dysbiosis in colorectal cancer (CRC) patients. PLoS ONE 6(1), e16393 (2011). https://doi.org/10.1371/journal.pone.0016393
Song, M., Chan, A.T., Sun, J.: Influence of the gut microbiome, diet, and environment on risk of colorectal cancer. Gastroenterol 158(2), 322–340 (2019). https://doi.org/10.1053/j.gastro.2019.06.048
Tariq, K., Ghias, K.: Colorectal cancer carcinogenesis: a review of mechanisms. Cancer Biol. Med. 13(1), 120–135 (2016). https://doi.org/10.28092/j.issn.2095-3941.2015.0103
Tiptiri-KourpetiA, S.K., Santarmaki, V., Aindelis, G., Tompoulidou, E., Lamprianidou, E.E., Saxami, G., Ypsilantis, P., Lampri, E.S., Simopoulos, C., Kotsianidis, I., Galanis, A., Kourkoutas, Y., Dimitrellou, D., Chlichlia, K.: Lactobacillus casei exerts anti-proliferative effects accompanied by apoptotic cell death and up-regulation of TRAIL in colon carcinoma cells. PLoS ONE 11(2), 0147960 (2016). https://doi.org/10.1371/journal.pone.0147960
Tripathy, A., Dash, J., Kancharla, S., Kolli, P., Mahajan, D., Senapati, S., Jena, M.K.: Probiotics: a promising candidate for management of colorectal cancer. Cancers 13(13), 3178 (2021). https://doi.org/10.3390/cancers13133178
Tsilimigras, M.C., Fodor, A., Jobin, C.: Carcinogenesis and therapeutics: the microbiota perspective. Nat. Microbio. 2, 17008 (2017). https://doi.org/10.1038/nmicrobiol.2017.8
Vogtmann, E., Hua, X., Zeller, G., Sunagawa, S., Voigt, A.Y., Hercog, R., Goedert, J.J., Shi, J., Bork, P., Sinha, R.: Colorectal cancer and the human gut microbiome: reproducibility with whole-genome shotgun sequencing. PLoS ONE 11(5), e0155362 (2016). https://doi.org/10.1371/journal.pone.0155362
Wang, T., Cai, G., Qiu, Y., Fei, N., Zhang, M., Pang, X., Jia, W., Cai, S., Zhao, L.: Structural segregation of gut microbiota between colorectal cancer patients and healthy volunteers. ISME J. 6(2), 320–329 (2012). https://doi.org/10.1038/ismej.2011.109
Weir, T.L., Manter, D.K., Sheflin, A.M., Barnett, B.A., Heuberger, A.L., Ryan, E.P.: Stool microbiome and metabolome differences between colorectal cancer patients and healthy adults. PLoS ONE 8, 1–10 (2013)
Weiss, G.A., Hennet, T.: Mechanisms and consequences of intestinal dysbiosis. Cell Mol. Life Sci. 74(16), 2959–2977 (2017). https://doi.org/10.1007/s00018-017-2509-x
Wu, H.J., Wu, E.: The role of gut microbiota in immune homeostasis and autoimmunity. Gut Microbes 3(1), 4–14 (2012a). https://doi.org/10.4161/gmic.19320
Wu, H.J., Wu, E.: The role of gut microbiota in immune homeostasis and autoimmunity. Gut Microbes (2012b). https://doi.org/10.4161/gmic.19320
Yavari, M., Ahmadizadeh, C.: Effect of the cellular extract of co-cultured Lactobacillus casei on BAX and human β-defensin 2 genes expression in HT29 cells. Horizon Med. Sci. 26(4), 364–381 (2020). https://doi.org/10.32598/hms.26.4.3277.1
Yu, J., Feng, Q., Wong, S.H., Zhang, D., Liang, Q., Qin, Y., Tang, L., Zhao, H., Stenvang, J., Li, Y., Wang, X., Xu, X., Chen, N., Wu, W.K.K., Al-Aama, J., Nielsen, H.J., Kiilerich, P., Jensen, B.A.H., Yau, T.O., Wang, J.: Metagenomic analysis of faecal microbiome as a tool towards targeted non-invasive biomarkers for colorectal cancer. Gut 66(1), 70–78 (2017)
Zhang, M., Fan, X., Fang, B., Zhu, C., Zhu, J., Ren, F.: Effects of Lactobacillus salivarius Ren on cancer prevention and intestinal microbiota in 1, 2-dimethylhydrazine-induced rat model. J. Microbiol 53(6), 398–405 (2015). https://doi.org/10.1007/s12275-015-5046-z
Zhuo, Q., Yu, B., Zhou, J., Zhang, J., Zhang, R., Xie, J., Wang, Q., Zhao, S.: Lysates of Lactobacillus acidophilus combined with CTLA-4-blocking antibodies enhance antitumor immunity in a mouse colon cancer model. Sci. Rep. 9(1), 20128 (2019). https://doi.org/10.1038/s41598-019-56661-y
Zisman, A.L., Nickolov, A., Brand, R.E., Gorchow, A., Roy, H.K.: Associations between the age at diagnosis and location of colorectal cancer and the use of alcohol and tobacco: implications for screening. Arch. Intern. Med. 166(6), 629–634 (2006). https://doi.org/10.1001/archinte.166.6.629
Zhu, Z., Ren, J., Michail, S., Sun, F.: MicroPro: using metagenomic unmapped reads to provide insights into human microbiota and disease associations. Genome Biol. 20(1), 154 (2019). https://doi.org/10.1186/s13059-019-1773-5
Zou, S., Fang, L., Lee, M.H.: Dysbiosis of gut microbiota in promoting the development of colorectal cancer. Gastroenterol. Rep. 6(1), 1–12 (2018). https://doi.org/10.1093/gastro/gox03110.1136/gutjnl-2015-309800
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Arora, R., Sharma, S. & Kumar, B. Colorectal cancer: risk factors and potential of dietary probiotics in its prevention. Proc.Indian Natl. Sci. Acad. 88, 528–541 (2022). https://doi.org/10.1007/s43538-022-00083-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s43538-022-00083-4